Dudediligence.

Relmada Therapeutics, Inc

RLMDNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Reported ·

$4,030,050

0 sales · 10 buys

Oct 2025 to Sep 2026

REPORTED · FORM 4Oct 2025 to Sep 2026N2025DJ2026FMAMJJASO2025-11-05: Kelly Paul Edward, bought2025-11-05: Shenouda Maged, bought2025-11-05: TRAVERSA SERGIO, bought2025-11-05: Ence Chuck, bought2025-12-15: Shenouda Maged, bought2025-12-15: TRAVERSA SERGIO, bought2026-09-09: TRAVERSA SERGIO, bought2026-09-09: Shenouda Maged, bought
under a no plan named▲ buysize is dollars

Form 4 filings, newest first

2026-09-09TRAVERSA SERGIO$828,000
▲ bought200,000 shno plan namedForm 4 ↗
2026-09-09Shenouda Maged$843,990
▲ bought200,000 shno plan namedForm 4 ↗
2025-12-15Shenouda Maged$48,060
▲ bought11,665 shno plan namedForm 4 ↗
2025-12-15TRAVERSA SERGIO$113,300
▲ bought27,500 shno plan namedForm 4 ↗
2025-11-05Kelly Paul Edward$198,000
▲ bought90,000 shno plan namedForm 4 ↗
2025-11-05Shenouda Maged$1,100,000
▲ bought500,000 shno plan namedForm 4 ↗
2025-11-05TRAVERSA SERGIO$599,500
▲ bought272,500 shno plan namedForm 4 ↗
2025-11-05Ence Chuck$299,200
▲ bought136,000 shno plan namedForm 4 ↗